Adaptive Biotechnologies vs Pyxis Diagnostics
Adaptive Biotechnologies vs Pyxis Diagnostics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Pyxis Diagnostics on 51/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 51/100
- agent readiness: 39/100 against 22/100
- domain rating: 61/100 against 3/100
- funding raised: $300M against $10.0M
Pyxis Diagnostics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adaptive Biotechnologies | Pyxis Diagnostics |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | Developing novel diagnostics to predict patient response to immunotherapy. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | Healthcare, Immunotherapy, Oncology, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Software |
| Founded | 2009 | 2017 |
| Headquarters | Seattle, United States | San Diego, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Pyxis Diagnostics |
|---|---|---|
| Employees | Not published | 3 |
| Headcount growthLast 12 months | Not published | -39.5% |
| Total funding | $300M | $10.0M |
| Latest round | Series D | Seed |
| LinkedIn followers | Not published | 398 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Pyxis Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 51/100 |
| Traction | Not published | 41/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | Not published | 26/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 3/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Pyxis Diagnostics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Wix |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Not detected |
Adaptive Biotechnologies vs Pyxis Diagnostics: common questions
Which is better, Adaptive Biotechnologies or Pyxis Diagnostics?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Pyxis Diagnostics compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 51/100), agent readiness (39/100 against 22/100), domain rating (61/100 against 3/100), funding raised ($300M against $10.0M).
Read the full Adaptive Biotechnologies review and pricing or the Pyxis Diagnostics review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.